Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Cantor Fitzgerald
Chubb
Farmers Insurance
Express Scripts
Medtronic
Fuji
QuintilesIMS

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209296

« Back to Dashboard

NDA 209296 describes CINVANTI, which is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the CINVANTI profile page.

The generic ingredient in CINVANTI is aprepitant. There are twenty-five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
Summary for 209296
Tradename:CINVANTI
Applicant:Heron Theraps Inc
Ingredient:aprepitant
Patents:5
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 209296
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CINVANTI aprepitant EMULSION;INTRAVENOUS 209296 NDA Heron Therapeutics 47426-201 47426-201-01 1 VIAL, GLASS in 1 CARTON (47426-201-01) > 18 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:EMULSION;INTRAVENOUSStrength130MG/18ML (7.2MG/ML)
Approval Date:Nov 9, 2017TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Sep 18, 2035Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF NAUSEA AND VOMITING, INCLUDING THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY OR MODERATELY EMETOGENIC CANCER CHEMOTHERAPY
Patent:➤ Sign UpPatent Expiration:Sep 18, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF NAUSEA AND VOMITING, INCLUDING THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY OR MODERATELY EMETOGENIC CANCER CHEMOTHERAPY
Patent:➤ Sign UpPatent Expiration:Sep 18, 2035Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Express Scripts
McKesson
QuintilesIMS
Boehringer Ingelheim
Fuji
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.